Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AB Science
Biotech
AB halts masitinib trials after discovering heart disease worry
The cessation of enrollment and treatment initiation deals yet another blow to a drug that has suffered a long string of regulatory setbacks.
Nick Paul Taylor
Jun 2, 2021 8:10am
Orion takes repurposed heart drug into phase 3 for ALS
Jul 6, 2018 9:48am
EuroBiotech: More Articles of Note
Sep 21, 2017 10:16am
AB Science trumpets phase 3 ALS data, but investors are unmoved
May 19, 2017 8:21am
Analysts lay into AB Science after regulatory misstep
May 15, 2017 7:00am
